The first step in implementing our solution is for Benchsci to apply its current technology to analyzing literature on pharmacodynamics. In 1994, the FDA started encouraging the publication of pharmacodynamic profiles in clinical trial results, leading to an increase in information on the field. Since then we have collected a large number of papers on pharmacodynamics, so we could easily apply Benchsci’s technology to pulling out and consolidating the resources already available.
Step 1: 2-4 Months
The next step would be creating a risk analysis and dosage tool for Benchsci. We can combine the new information that is pulled on pharmacodynamics with Benchsci’s risk detector tool to increase accuracy and efficiency. On top of that, the other information from the profiles can be added to Benchsci’s network of information as a dosage tool that would allow scientists to explore the different factors that could impact dosage and pick an accurate starting point.
Step 2: 4-6 Months
Once Benchsci has analyzed the literature and created a dosage/risk analysis tool, they could then move on to potentially creating their own, easy-to-use database for pharmacodynamics information. Currently, the amount of databases for this specific topic is limited, and creating a database would be another way for Benchsci to break into the market and compete with other competitors such as consulting firms like Nuventra.
Step 3: 1-2 Years